Breaking News Headlines Today | Ground News

See every side of every news story

urologytimes.com image

News from urologytimes.com

We’ve assigned a media bias rating of unknown to urologytimes.com. You can read more about our methodology here.

urologytimes.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about urologytimes.com

Where is urologytimes.com located?urologytimes.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top urologytimes.com News

FDA Grants Priority Review to sBLA for EV Plus Pembrolizumab in Cisplatin-Ineligible MIBC

West Virginia · West Virginia

FDA Grants Priority Review to sBLA for EV Plus Pembrolizumab in Cisplatin-Ineligible MIBC

64% Center coverage: 30 sources

The PDUFA target action date for the application is April 7, 2026.See the Story

Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

Toronto, ON · Toronto

Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

67% Left coverage: 3 sources

TORONTO and HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immu…See the Story

ctDNA-Guided Care: Where Are We in Bladder and Colon Cancer?

ctDNA-Guided Care: Where Are We in Bladder and Colon Cancer?

From intensifying therapy in ctDNA-positive bladder cancer to scaling it back in ctDNA-negative colon cancer, new data from ESMO 2025 signal a shift toward precision-guided adjuvant care. Medscape Medical News Source link : https://www.medscape.com/viewarticle/ctdna-guided-care-where-are-we-bladder-and-colon-cancer-2025a1000ssm?src=rss Author : Publish date : 2025-10-23 04:54:00 Copyright for syndicated content belongs to the linked Source. The …See the Story

Breaking News Topics Related to urologytimes.com